Market Overview

5 Drug Stores Stocks With The Highest Revenue Estimates

Share:
Related CVS
Benzinga's M&A Chatter for Thursday May 21, 2015
Top 10 Most Popular American Stores
CVS Confirms Omnicare Buy (Investor's Business Daily)
Related WAG
IPO Outlook: API-Focused Software Tech Company Apigee Is A Silent Growth Story
Jana Partners' Barry Rosenstein: 'The Walgreens Situation Is Terrific'

Below are the top drug stores stocks in terms of revenue estimate for the current year.

Analysts expect CVS Caremark (NYSE: CVS) to post revenue of $122.80 billion for the year ending December, 2012. CVS Caremark's trailing-twelve-month revenue is $116.50 billion.

Walgreen Co (NYSE: WAG) is expected to report revenue of $71.73 billion for the year ending August, 2012. Walgreen's trailing-twelve-month revenue is $72.53 billion.

Rite Aid (NYSE: RAD) is likely to post revenue of $25.42 billion in the year ending February, 2013. Rite Aid's trailing-twelve-month revenue is $26.20 billion.

GNC Holdings (NYSE: GNC) may report revenue of $2.43 billion in the year ending December, 2012. GNC Holdings' trailing-twelve-month revenue is $2.29 billion.

PharMerica (NYSE: PMC) is estimated to post revenue of $1.84 billion in the year ending December, 2012. PharMerica's trailing-twelve-month revenue is $1.97 billion.

Posted-In: Drug Stores Industry Highest Revenue EstimatesTrading Ideas

 

Related Articles (CVS + GNC)

Around the Web, We're Loving...